359 related articles for article (PubMed ID: 36144783)
1. The Potential Role of Apigenin in Cancer Prevention and Treatment.
Rahmani AH; Alsahli MA; Almatroudi A; Almogbel MA; Khan AA; Anwar S; Almatroodi SA
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144783
[TBL] [Abstract][Full Text] [Related]
2. Rationalizing the therapeutic potential of apigenin against cancer.
Ahmed SA; Parama D; Daimari E; Girisa S; Banik K; Harsha C; Dutta U; Kunnumakkara AB
Life Sci; 2021 Feb; 267():118814. PubMed ID: 33333052
[TBL] [Abstract][Full Text] [Related]
3. The flavonoid apigenin reduces prostate cancer CD44(+) stem cell survival and migration through PI3K/Akt/NF-κB signaling.
Erdogan S; Doganlar O; Doganlar ZB; Serttas R; Turkekul K; Dibirdik I; Bilir A
Life Sci; 2016 Oct; 162():77-86. PubMed ID: 27569589
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Properties of 4', 5, 7-Trihydroxyflavone (Apigenin) and Its Impact on Cell Signaling Pathways.
Abid R; Ghazanfar S; Farid A; Sulaman SM; Idrees M; Amen RA; Muzammal M; Shahzad MK; Mohamed MO; Khaled AA; Safir W; Ghori I; Elasbali AM; Alharbi B
Molecules; 2022 Jul; 27(13):. PubMed ID: 35807549
[TBL] [Abstract][Full Text] [Related]
5. Insights into Pharmacological Potential of Apigenin through Various Pathways on a Nanoplatform in Multitude of Diseases.
Waheed A; Zameer S; Ashrafi K; Ali A; Sultana N; Aqil M; Sultana Y; Iqbal Z
Curr Pharm Des; 2023; 29(17):1326-1340. PubMed ID: 37254541
[TBL] [Abstract][Full Text] [Related]
6. Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner.
Chen M; Wang X; Zha D; Cai F; Zhang W; He Y; Huang Q; Zhuang H; Hua ZC
Sci Rep; 2016 Oct; 6():35468. PubMed ID: 27752089
[TBL] [Abstract][Full Text] [Related]
7. Apigenin, a dietary flavonoid, sensitizes human T cells for activation-induced cell death by inhibiting PKB/Akt and NF-kappaB activation pathway.
Xu L; Zhang L; Bertucci AM; Pope RM; Datta SK
Immunol Lett; 2008 Nov; 121(1):74-83. PubMed ID: 18812189
[TBL] [Abstract][Full Text] [Related]
8. Apigenin Reduces Survival of Choriocarcinoma Cells by Inducing Apoptosis via the PI3K/AKT and ERK1/2 MAPK Pathways.
Lim W; Park S; Bazer FW; Song G
J Cell Physiol; 2016 Dec; 231(12):2690-9. PubMed ID: 26970256
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Cell Proliferation and Metastasis by Scutellarein Regulating PI3K/Akt/NF-κB Signaling through PTEN Activation in Hepatocellular Carcinoma.
Ha SE; Kim SM; Vetrivel P; Kim HH; Bhosale PB; Heo JD; Lee HJ; Kim GS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445559
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells.
Yang J; Pi C; Wang G
Biomed Pharmacother; 2018 Jul; 103():699-707. PubMed ID: 29680738
[TBL] [Abstract][Full Text] [Related]
11. Targeting the PI3K/Akt/mTOR axis by apigenin for cancer prevention.
Tong X; Pelling JC
Anticancer Agents Med Chem; 2013 Sep; 13(7):971-8. PubMed ID: 23272913
[TBL] [Abstract][Full Text] [Related]
12. Resources for Human Health from the Plant Kingdom: The Potential Role of the Flavonoid Apigenin in Cancer Counteraction.
Fossatelli L; Maroccia Z; Fiorentini C; Bonucci M
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203418
[TBL] [Abstract][Full Text] [Related]
13. Scutellarin suppresses cartilage destruction in osteoarthritis mouse model by inhibiting the NF-κB and PI3K/AKT signaling pathways.
Wang W; Li J; Li F; Peng J; Xu M; Shangguan Y; Li Y; Zhao Y; Qiu C; Qu R; Li W; Zhang C; Zhang T
Int Immunopharmacol; 2019 Dec; 77():105928. PubMed ID: 31711940
[TBL] [Abstract][Full Text] [Related]
14. Apigenin: Molecular Mechanisms and Therapeutic Potential against Cancer Spreading.
Naponelli V; Rocchetti MT; Mangieri D
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791608
[TBL] [Abstract][Full Text] [Related]
15. Effects and Mechanisms of Luteolin, a Plant-Based Flavonoid, in the Prevention of Cancers via Modulation of Inflammation and Cell Signaling Molecules.
Almatroodi SA; Almatroudi A; Alharbi HOA; Khan AA; Rahmani AH
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474604
[TBL] [Abstract][Full Text] [Related]
16. Apigenin as an anticancer agent.
Imran M; Aslam Gondal T; Atif M; Shahbaz M; Batool Qaisarani T; Hanif Mughal M; Salehi B; Martorell M; Sharifi-Rad J
Phytother Res; 2020 Aug; 34(8):1812-1828. PubMed ID: 32059077
[TBL] [Abstract][Full Text] [Related]
17. Apigenin sensitizes colon cancer cells to antitumor activity of ABT-263.
Shao H; Jing K; Mahmoud E; Huang H; Fang X; Yu C
Mol Cancer Ther; 2013 Dec; 12(12):2640-50. PubMed ID: 24126433
[TBL] [Abstract][Full Text] [Related]
18. Apigenin-induced cell cycle arrest is mediated by modulation of MAPK, PI3K-Akt, and loss of cyclin D1 associated retinoblastoma dephosphorylation in human prostate cancer cells.
Shukla S; Gupta S
Cell Cycle; 2007 May; 6(9):1102-14. PubMed ID: 17457054
[TBL] [Abstract][Full Text] [Related]
19. Apigenin suppresses the apoptosis of H9C2 rat cardiomyocytes subjected to myocardial ischemia‑reperfusion injury via upregulation of the PI3K/Akt pathway.
Zhou Z; Zhang Y; Lin L; Zhou J
Mol Med Rep; 2018 Aug; 18(2):1560-1570. PubMed ID: 29901074
[TBL] [Abstract][Full Text] [Related]
20. Apigenin reduces the Toll-like receptor-4-dependent activation of NF-κB by suppressing the Akt, mTOR, JNK, and p38-MAPK.
Kim A; Lee CS
Naunyn Schmiedebergs Arch Pharmacol; 2018 Mar; 391(3):271-283. PubMed ID: 29264665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
